共 50 条
- [1] Trends in the risks and benefits to patients with cancer in phase 1 clinical trials JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (07): : 795 - 795
- [2] Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (17): : 2130 - 2140
- [3] Defining benefits and risks for SERMs in clinical trials and clinical practice SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 304 - 314
- [5] Commercializing clinical trials - Risks and benefits of the CRO boom NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (14): : 1365 - 1368
- [6] Weighing the benefits and risks in clinical trials and practice - Introduction SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS), 2001, 949 : 279 - 279
- [7] Framing the Benefits of Cancer Clinical Trials ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2010, 164 (03): : 293 - 294